×
About 1,308 results

ALLMedicine™ Pediatric Hematology Center

Research & Reviews  400 results

Integration of Patient-reported Outcome Measures in Pediatric Hematology: A Qualitative...
https://doi.org/10.1097/MPH.0000000000002465
Journal of Pediatric Hematology/oncology; Graham JMI, Dong SX et. al.

Apr 25th, 2022 - Patient-reported outcome measures (PROMs) are self-reported questionnaires that allow patients and families to evaluate health-related experiences without influence or oversight from health care professionals. This study aimed to rate the relevanc...

Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic...
https://doi.org/10.3324/haematol.2021.280016
Haematologica Anastasopoulou S, Nielsen RL et. al.

Apr 1st, 2022 - Central nervous system (CNS) toxicity is common at diagnosis and during treatment of pediatric acute lymphoblastic leukemia (ALL). We studied CNS toxicity in 1 464 children aged 1.0-17.9 years, diagnosed with ALL and treated according to the Nordi...

Pediatric hematology/oncology physician and nurse practitioner attitudes towards the CO...
https://doi.org/10.1080/21645515.2022.2048560
Human Vaccines & Immunotherapeutics; Miller ME, Rahim MQ et. al.

Mar 29th, 2022 - As of 05/28/2021, SARS-CoV-2 (COVID-19) had caused 3.9 million infections in the United States (US) pediatric population since its discovery in December of 2019. The development and expansion of vaccination has markedly changed the shape of the ep...

An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared D...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943226
Journal of Pediatric Hematology/oncology; Real FJ, Hood AM et. al.

Mar 24th, 2022 - Although hydroxyurea (HU) is an effective treatment for sickle cell anemia, uptake remains low. Shared decision-making (SDM) is a recommended strategy for HU initiation to elicit family preferences; however, clinicians lack SDM training. We implem...

see more →

Guidelines  3 results

Japan society of clinical oncology/Japanese society of medical oncology-led clinical re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046581
International Journal of Clinical Oncology; Naito Y, Mishima S et. al.

Jan 25th, 2020 - The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we published provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA...

APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease Fr...
https://doi.org/10.1177/1043454215591954
Journal of Pediatric Oncology Nursing : Official Journal ... Bryant R, Porter JS et. al.

Oct 16th, 2015 - With advances in medical care, the majority of children with sickle cell disease are surviving to adulthood. Patients, families, and providers now face the need for this growing population to move from pediatric- to adult-focused care. In order to...

Recommendations for the use of long-term central venous catheter (CVC) in children with...
https://doi.org/10.1007/s00277-015-2481-1
Annals of Hematology; Giordano P, Saracco P et. al.

Aug 25th, 2015 - Central venous catheters (CVC), used for the management of children with hemato-oncological disorders, are burdened by a significant incidence of mechanical, infective, or thrombotic complications. These complications favor an increasing risk in p...

see more →

Clinicaltrials.gov  22 results

Peripheral Venous Catheter Related Blood Stream Infections
https://clinicaltrials.gov/ct2/show/NCT05139628

Mar 2nd, 2022 - Peripheral intravenous catheters (PIVCs) are small flexible tubes that are vital for the delivery of therapies, such as fluids, drugs, and blood transfusions that are required in up to 70% of hospitalized patients. The PIVC is introduced through t...

Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
https://clinicaltrials.gov/ct2/show/NCT04334993

May 7th, 2021 - This is a national, multicenter, phase II clinical trial to evaluate the potential benefit of a modified pediatric-based approach in young adults with Ph-neg ALL. Safety and efficacy of pre-transplant antibody-based consolidation in high-risk pati...

Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.
https://clinicaltrials.gov/ct2/show/NCT03541330

Apr 22nd, 2021 - The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille

Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer
https://clinicaltrials.gov/ct2/show/NCT04778917

Mar 3rd, 2021 - This is a randomized, controlled, single blind trial(Researchers are not blind, patients are blind). 1.Patient population .Experience group We will recruit 93 cases in our trial.All of them are with simple pneumonia and are hospitalized in the res...

The Effect of Using Interactive Mobile Application for the Management of Chemotherapy- Induced Nausea and Vomiting in Children
https://clinicaltrials.gov/ct2/show/NCT04693832

Jan 5th, 2021 - Intensive chemotherapy protocols are the most commonly used treatments in childhood cancers. While these protocols increase recovery rates, they may also cause some undesirable side effects. Nausea and vomiting is one of the most common toxic side...

see more →

News  95 results

Heavy Menstrual Bleeding in Teens: A 'Shematologist's' Approach
https://www.medscape.com/viewarticle/970614

Mar 30th, 2022 - This transcript has been edited for clarity. Christopher J. Chiu, MD: Welcome back to The Cribsiders. This is our Medscape video recap of one of our recent podcast episodes. Justin, what are we reviewing today? Justin L. Berk, MD, MPH, MBA: We had...

Dr. Shereck Shares How She Makes Medical Education More Fun and Accessible
https://www.onclive.com/view/dr-shereck-shares-how-she-makes-medical-education-more-fun-and-accessible

Mar 21st, 2022 - Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute...

Dr. Shereck Discusses Helping Oncology Fellows Find a Career
https://www.onclive.com/view/dr-shereck-on-helping-fellows-find-a-career

Mar 21st, 2022 - Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute...

Net Guides: Childhood Tumors
https://www.onclive.com/view/net-guides-childhood-tumors

Mar 15th, 2022 - //THE ONLINE ONCOLOGIST™ American Society of Pediatric Hematology/Oncology The American Society of Pediatric Hematology/Oncology (ASPHO) is a multidisciplinary organization that works to promote the care of children and adolescents with blo...

Dr. Navai on Treatment Options in Relapsed/Refractory Sarcoma
https://www.onclive.com/view/dr-navai-on-treatment-options-in-relapsedrefractory-sarcoma

Oct 6th, 2021 - Shoba A. Navai, MD, an assistant professor, Department of Pediatrics, Section of Pediatric Hematology and Oncology, at Baylor College of Medicine, Texas Children’s Hospital, discusses treatment options for patients with relapsed/refractory sarcoma...

see more →

Patient Education  3 results see all →